Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference48 articles.
1. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B;Akerley;Cancer,2003
2. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: a gynecologic oncology group study;Alberts;Gynecol. Oncol..,2012
3. Peripheral nerve damage associated with administration of taxanes in patients with cancer;Argyriou;Crit. Rev. Oncol./Hematol.,2008
4. Intraperitoneal cisplatin and, 2019 intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N. Engl. J. Med.,2006
5. A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non–small-cell lung cancer;Camidge;J. Thorac. Oncol..,2014
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02
2. Innovative strategies for effective paclitaxel delivery: Recent developments and prospects;Journal of Oncology Pharmacy Practice;2024-01-10
3. Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database;Expert Opinion on Drug Safety;2023-04-17
4. Efficacy and safety of nanopaclitaxel formulation for cancer treatment: evidence from randomized clinical trials;Nanomedicine;2023-04
5. A Prospective, Randomized, Placebo-Controlled Study Assessing the Efficacy of Chinese Herbal Medicine (Huangqi Guizhi Wuwu Decoction) in the Treatment of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy;Journal of Clinical Medicine;2023-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3